Embecta securities class action lawsuit
Analysis based on 7 articles · First reported Jul 10, 2026 · Last updated Jul 16, 2026
The lawsuit may negatively impact Embecta's stock price and investor confidence. The allegations of misleading guidance could lead to financial penalties and reputational damage.
A class action lawsuit has been filed against Embecta Corp. (NASDAQ: EMBC) and certain of its officers by Bronstein, Gewirtz & Grossman, LLC, LLC, alleging violations of federal securities laws. The complaint claims that between November 25, 2025 and May 4, 2026, Embecta made materially false and misleading statements about its business and prospects, particularly regarding its pen needle sales and financial guidance. On May 5, 2026, Embecta reported a revenue decline of over 14% and lowered its fiscal year 2026 guidance, contrary to earlier positive statements. Investors who purchased Embecta securities during the class period have until August 17, 2026 to seek lead plaintiff status.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard